Patients with certain inflammatory skin diseases have multiple risk factors for venous thromboembolism (VTE). The objective of the study was to determine whether atopic dermatitis (AD), psoriasis, pemphigus, pemphigoid and/or hidradenitis is associated with VTE in US adults. Data were analyzed from the 2002–2012 Nationwide Inpatient Sample, a representative cohort of US hospitalizations (N = 72,512,581 adults, including 1,389,292 with VTE). In multivariable logistic regression models including age, sex, insurance, household income and race/ethnicity, hospitalization for AD (adjusted odds ratio [95% confidence intervals] 1.22 [1.17–1.27]), pemphigus (1.96 [1.68–2.28]) and pemphigoid (1.64 [1.47–1.83]) was associated with VTE. These associations remained significant in virtually all patient subsets, including males and females, different age groups and those with and without long-term corticosteroid use. In particular, AD, pemphigus and pemphigoid were each associated with DVT and PE. VTE was associated with increased inpatient length of stay, cost of care and mortality across all the inflammatory skin diseases. HS and psoriasis were not consistently associated with VTE. AD, pemphigus and pemphigoid and some subsets of patients with HS were associated with higher odds of hospitalization for VTE. Patients with these inflammatory skin diseases may benefit from increased screening and prevention of VTE.
This is a preview of subscription content,to check access.
Access this article
Adjusted odds ratio
Nationwide Inpatient Sample
Deep vein thrombosis
ISTH Steering Committee for World Thrombosis Day (2014) Thrombosis: a major contributor to global disease burden. J Thromb Haemost 12(10):1580–1590
Maynard G (2016) Preventing hospital-associated venous thromboembolism: a guide for effective quality improvement. 2 edn, Agency for Healthcare Research and Quality, Rockville, MD. https://www.ahrq.gov/sites/default/files/publications/files/vteguide.pdf
Anderson FA Jr, Spencer FA (2003) Risk factors for venous thromboembolism. Circulation 107(23 Suppl 1):I9–I16
Ramagopalan SV, Wotton CJ, Handel AE, Yeates D, Goldacre MJ (2011) Risk of venous thromboembolism in people admitted to hospital with selected immune-mediated diseases: record-linkage study. BMC Med 9:1
Chung WS, Lin CL, Sung FC, Lu CC, Kao CH (2014) Increased risk of venous thromboembolism in patients with dermatomyositis/polymyositis: a nationwide cohort study. Thromb Res 134(3):622–626
Ahlehoff O, Gislason GH, Lindhardsen J et al (2011) Psoriasis carries an increased risk of venous thromboembolism: a Danish nationwide cohort study. PLoS ONE 6(3):e18125
Johannesdottir SA, Horvath-Puho E, Dekkers OM et al (2013) Use of glucocorticoids and risk of venous thromboembolism: a nationwide population-based case-control study. JAMA Intern Med 173(9):743–752
Huerta C, Johansson S, Wallander MA, Garcia Rodriguez LA (2007) Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom. Arch Intern Med 167(9):935–943
U.S. Department of Labor, Bureau of Labor Statistics. https://www.bls.gov/news.release/archives/cpi_07172015.pdf
Leshem YA, Atzmony L, Dudkiewicz I, Hodak E, Mimouni D (2017) Venous thromboembolism in patients with pemphigus: a cohort study. J Am Acad Dermatol 77(2):256–260
Nastalek M, Wojas-Pelc A, Undas A (2010) Plasma fibrin clot properties in atopic dermatitis: links between thrombosis and atopy. J Thromb Thrombolysis 30(2):121–126
Miller IM, Ahlehoff O, Ibler K et al (2016) Hidradenitis suppurativa may not be associated with venous thromboembolia: results from a large Danish cross-sectional study. J Dermatol Sci 81(1):61–63
Waljee AK, Rogers MA, Lin P et al (2017) Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study. BMJ 357:j1415
Zoller B, Li X, Sundquist J, Sundquist K (2012) Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden. Lancet 379(9812):244–249
Davidovici BB, Sattar N, Prinz J et al (2010) Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions. J Invest Dermatol 130(7):1785–1796
Esmon CT (2005) The interactions between inflammation and coagulation. Br J Haematol 131(4):417–430
Kasperska-Zajac A, Brzoza Z, Rogala B (2008) Platelet function in cutaneous diseases. Platelets 19(5):317–321
Chung WS, Peng CL, Lin CL et al (2014) Rheumatoid arthritis increases the risk of deep vein thrombosis and pulmonary thromboembolism: a nationwide cohort study. Ann Rheum Dis 73(10):1774–1780
Grainge MJ, West J, Card TR (2010) Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study. Lancet 375(9715):657–663
Saleh T, Matta F, Yaekoub AY, Danescu S, Stein PD (2011) Risk of venous thromboembolism with inflammatory bowel disease. Clin Appl Thromb Hemost 17(3):254–258
This publication was made possible with support from the Agency for Healthcare Research and Quality (AHRQ), grant number K12 HS023011.
Conflict of interest
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
About this article
Cite this article
Shaheen, M.S., Silverberg, J.I. Association of inflammatory skin diseases with venous thromboembolism in US adults. Arch Dermatol Res 313, 281–289 (2021). https://doi.org/10.1007/s00403-020-02099-6